Fig. 7.
Fig. 7. Scatchard analysis of transferrin binding to K562 cells. Cells were preincubated for 24 hours with 50 U/mL human recombinant Epo (Epo), 100 μmol/L desferrioxamine (Dfo), or no addition (C) and were then incubated for 30 minutes on ice with 125I-transferrin. Nonspecific binding was determined by incubating with a 200-fold excess of unlabeled transferrin. The number of bindings sites per cell after correcting for nonspecific binding were, for control, n = 0.45 × 105 (dissociation constant [kd] = 41 nmol/L); for Epo-treated cells, n = 1.11 × 105 (kd = 43 nmol/L); and for desferrioxamine-treated cells, n = 2.92 × 105 (kd = 43 nmol/L). The results of one of three similar experiments are shown.

Scatchard analysis of transferrin binding to K562 cells. Cells were preincubated for 24 hours with 50 U/mL human recombinant Epo (Epo), 100 μmol/L desferrioxamine (Dfo), or no addition (C) and were then incubated for 30 minutes on ice with 125I-transferrin. Nonspecific binding was determined by incubating with a 200-fold excess of unlabeled transferrin. The number of bindings sites per cell after correcting for nonspecific binding were, for control, n = 0.45 × 105 (dissociation constant [kd] = 41 nmol/L); for Epo-treated cells, n = 1.11 × 105 (kd = 43 nmol/L); and for desferrioxamine-treated cells, n = 2.92 × 105 (kd = 43 nmol/L). The results of one of three similar experiments are shown.

Close Modal

or Create an Account

Close Modal
Close Modal